Platelet-rich plasma injection vs. operative treatment for lateral elbow tendinosis: a systematic review and meta-analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Chul-Ho | - |
dc.contributor.author | Park, Yong-Beom | - |
dc.contributor.author | Lee, Jae-Sung | - |
dc.contributor.author | Jung, Hyoung-Seok | - |
dc.date.accessioned | 2023-03-08T08:49:49Z | - |
dc.date.available | 2023-03-08T08:49:49Z | - |
dc.date.issued | 2022-02 | - |
dc.identifier.issn | 1058-2746 | - |
dc.identifier.issn | 1532-6500 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/61693 | - |
dc.description.abstract | Background: Although surgical treatment is considered reliable for lateral elbow tendinosis, local injection therapy may be preferable, as it avoids surgery. Among a number of local injections, platelet-rich plasma has been used successfully to treat lateral elbow tendinosis. The purpose of this study was to compare the outcomes in patients treated with either platelet-rich plasma injections or surgery for lateral elbow tendinosis using a systematic literature review and meta-analysis. Methods: MEDLINE, Embase, and Cochrane Library databases were systematically searched for studies published before March 1, 2021, that compared platelet-rich plasma with operative treatment for lateral elbow tendinosis. The pooled analysis was designed to compare the visual analog scale scores and the Patient-Related Tennis Elbow Evaluation scores between the platelet-rich plasma and surgical treatment groups at serial time points. Results: We included 5 studies involving 340 patients with lateral elbow tendinosis, comprising of 154 patients treated with platelet-rich plasma and 186 patients who underwent surgical treatment. The pooled analysis showed no statistically significant differences in the visual analog scale scores at any of the follow-up time points, namely, 2 months (mean difference [MD] 1.11, 95% confidence interval [CI] -2.51 to 4.74, P = .55, I-2 = 94%), 6 months (MD 0.80, 95% CI -2.83 to 4.42, P = .67, I-2 = 92%), and 12 months (MD -0.92, 95% CI -4.63 to 2.80, P = .63, I-2 = 93%) postintervention and in the Patient-Related Tennis Elbow Evaluation scores at 12 weeks (MD -1.86, 95% CI -22.30 to 18.58, P = .86, I-2 = 81%), 24 weeks (MD -3.33, 95% CI -21.82 to 15.17, P = .72, I-2 = 74%), and 52 weeks (MD -3.64, 95% CI -19.65 to 12.37, P = .66, I-2 = 69%) postintervention. Conclusions: Local platelet-rich plasma injections and surgical treatment produced equivalent pain scores and functional outcomes in patients with lateral elbow tendinosis. Thus, platelet-rich plasma injections may represent a reasonable alternative treatment for patients who are apprehensive to proceed with surgery or for poor surgical candidates. Level of evidence: Level III; Meta-Analysis (c) 2021 Journal of Shoulder and Elbow Surgery Board of Trustees. All rights reserved. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MOSBY-ELSEVIER | - |
dc.title | Platelet-rich plasma injection vs. operative treatment for lateral elbow tendinosis: a systematic review and meta-analysis | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.jse.2021.09.008 | - |
dc.identifier.bibliographicCitation | JOURNAL OF SHOULDER AND ELBOW SURGERY, v.31, no.2, pp 428 - 436 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000752560000031 | - |
dc.identifier.scopusid | 2-s2.0-85121239030 | - |
dc.citation.endPage | 436 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 428 | - |
dc.citation.title | JOURNAL OF SHOULDER AND ELBOW SURGERY | - |
dc.citation.volume | 31 | - |
dc.type.docType | Review | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | Platelet-rich plasma | - |
dc.subject.keywordAuthor | surgery | - |
dc.subject.keywordAuthor | elbow tendinosis | - |
dc.subject.keywordAuthor | lateral epicondylitis | - |
dc.subject.keywordAuthor | meta-analysis | - |
dc.subject.keywordPlus | RANDOMIZED CONTROLLED-TRIAL | - |
dc.subject.keywordPlus | CHRONIC TENNIS ELBOW | - |
dc.subject.keywordPlus | CORTICOSTEROID INJECTION | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | ARTHROSCOPIC TREATMENT | - |
dc.subject.keywordPlus | FOLLOW-UP | - |
dc.subject.keywordPlus | EPICONDYLITIS | - |
dc.subject.keywordPlus | RELEASE | - |
dc.subject.keywordPlus | TENDON | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.relation.journalResearchArea | Orthopedics | - |
dc.relation.journalResearchArea | Sport Sciences | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Orthopedics | - |
dc.relation.journalWebOfScienceCategory | Sport Sciences | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.